[Ip-health] FW: The Dangers of the Indian Government's Flirtation with U.S. Pharma and the Risks for India's Coherent, Pro-Public Health IP Policy
b.baker at neu.edu
Mon Oct 6 06:18:39 PDT 2014
...U.S. business interests and government officials are trying to sell the idea that heightened intellectual property protections in India are
essential to foreign investment, innovation, and achievement of public health goals.
Instead, heightened intellectual property rights will make India consumers captive to Big Pharma?s extortionate pricing....
Unfortunately, the joint communiqué issued at the end of Prime Minister Modi?s US visit shows deference by the US and Indian
governments to Big Pharma's pressure...
The Dangers of the Indian Government's Flirtation with U.S. Pharma and the Risks for India's Coherent, Pro-Public Health IP Policy
Professor Brook K. Baker, Senior Policy Analyst Health GAP
October 5, 2014
More information about the Ip-health